Two emerging pathways, anti-angiogenic FK506-binding protein-like (FKBPL) and pro-inflammatory galectin-3 (Gal-3), have been implicated in preeclampsia and associated cardiovascular complications [22, 23]. Here, FKBPL is linked to preeclampsia.